Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Suzanne M Shema. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Suzanne M Shema har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:ONXX / Onyx Pharmaceuticals Inc | EVP,GC and Corp. Secretary | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Suzanne M Shema. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Suzanne M Shema som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | −16 700 | 0 | −100,00 | ||||
2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | −24 563 | 0 | −100,00 | ||||
2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | −903 | 0 | −100,00 | ||||
2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | −16 510 | 0 | −100,00 | ||||
2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | −2 157 | 0 | −100,00 | ||||
2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | −12 489 | 0 | −100,00 | ||||
2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | −3 553 | 0 | −100,00 | ||||
2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | −3 281 | 0 | −100,00 | ||||
2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | −1 969 | 0 | −100,00 | ||||
2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | −1 214 | 0 | −100,00 | ||||
2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | −12 472 | 0 | −100,00 | ||||
2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −28 150 | 0 | −100,00 | 125,00 | −3 518 750 | ||
2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
U - Other | −6 468 | 28 150 | −18,68 | 125,00 | −808 500 | 3 518 750 | |
2013-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −802 | 16 042 | −4,76 | ||||
2013-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −796 | 25 466 | −3,03 | ||||
2013-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −583 | 18 667 | −3,03 | ||||
2013-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −656 | 5 250 | −11,11 | ||||
2013-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −1 215 | 13 686 | −8,15 | ||||
2013-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 052 | 34 618 | −10,48 | 131,86 | −534 297 | 4 564 729 |
2013-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 802 | 38 670 | 2,12 | 35,18 | 28 214 | 1 360 411 | |
2013-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 796 | 37 868 | 2,15 | 37,68 | 29 993 | 1 426 866 | |
2013-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 583 | 37 072 | 1,60 | 37,68 | 21 967 | 1 396 873 | |
2013-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 656 | 36 489 | 1,83 | 30,28 | 19 864 | 1 104 887 | |
2013-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 215 | 35 833 | 3,51 | 32,07 | 38 965 | 1 149 164 | |
2013-07-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −796 | 26 262 | −2,94 | ||||
2013-07-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −583 | 19 250 | −2,94 | ||||
2013-07-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −802 | 16 844 | −4,54 | ||||
2013-07-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −657 | 5 906 | −10,01 | ||||
2013-07-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −1 214 | 14 901 | −7,53 | ||||
2013-07-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 052 | 34 618 | −10,48 | 135,76 | −550 100 | 4 699 740 |
2013-07-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 796 | 38 670 | 2,10 | 37,68 | 29 993 | 1 457 086 | |
2013-07-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 583 | 37 874 | 1,56 | 37,68 | 21 967 | 1 427 092 | |
2013-07-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 802 | 37 291 | 2,20 | 35,18 | 28 214 | 1 311 897 | |
2013-07-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 657 | 36 489 | 1,83 | 30,28 | 19 894 | 1 104 887 | |
2013-07-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 214 | 35 832 | 3,51 | 32,07 | 38 933 | 1 149 132 | |
2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −796 | 27 058 | −2,86 | ||||
2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −584 | 19 833 | −2,86 | ||||
2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | −802 | 17 646 | −4,35 | ||||
2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −656 | 6 563 | −9,09 | ||||
2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −1 214 | 16 115 | −7,01 | ||||
2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 100 | 34 618 | −3,08 | 92,06 | −101 268 | 3 186 999 |
2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 952 | 35 718 | −7,63 | 90,91 | −268 376 | 3 247 241 |
2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 796 | 38 670 | 2,10 | 37,68 | 29 993 | 1 457 086 | |
2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 584 | 37 874 | 1,57 | 37,68 | 22 005 | 1 427 092 | |
2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 802 | 37 290 | 2,20 | 35,18 | 28 214 | 1 311 862 | |
2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 656 | 36 488 | 1,83 | 30,28 | 19 864 | 1 104 857 | |
2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 214 | 35 832 | 3,51 | 32,07 | 38 933 | 1 149 132 | |
2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −795 | 27 854 | −2,77 | ||||
2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −583 | 20 417 | −2,78 | ||||
2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −802 | 18 448 | −4,17 | ||||
2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −1 215 | 17 329 | −6,55 | ||||
2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −656 | 7 219 | −8,33 | ||||
2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 378 | 34 618 | −3,83 | 90,01 | −124 034 | 3 115 966 |
2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −802 | 35 996 | −2,18 | 89,99 | −72 172 | 3 239 280 |
2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 871 | 36 798 | −4,84 | 89,94 | −168 278 | 3 309 612 |
2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 795 | 38 669 | 2,10 | 37,68 | 29 956 | 1 457 048 | |
2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 583 | 37 874 | 1,56 | 37,68 | 21 967 | 1 427 092 | |
2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 802 | 37 291 | 2,20 | 35,18 | 28 214 | 1 311 897 | |
2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 215 | 36 489 | 3,44 | 32,07 | 38 965 | 1 170 202 | |
2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 656 | 35 274 | 1,89 | 30,28 | 19 864 | 1 068 097 | |
2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −803 | 19 250 | −4,00 | ||||
2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −796 | 28 649 | −2,70 | ||||
2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −583 | 21 000 | −2,70 | ||||
2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −1 214 | 18 544 | −6,14 | ||||
2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −656 | 7 875 | −7,69 | ||||
2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −803 | 34 618 | −2,27 | 89,16 | −71 596 | 3 086 551 |
2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 803 | 35 421 | 2,32 | 35,18 | 28 250 | 1 246 111 | |
2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 379 | 34 618 | −3,83 | 89,16 | −122 952 | 3 086 558 |
2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 796 | 35 997 | 2,26 | 37,68 | 29 993 | 1 356 367 | |
2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 583 | 35 201 | 1,68 | 37,68 | 21 967 | 1 326 374 | |
2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 870 | 34 618 | −5,12 | 89,19 | −166 790 | 3 087 673 |
2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 214 | 36 488 | 3,44 | 32,07 | 38 933 | 1 170 170 | |
2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 656 | 35 274 | 1,89 | 30,28 | 19 864 | 1 068 097 | |
2013-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 335 | 34 618 | −6,32 | 86,14 | −201 137 | 2 981 995 |
2013-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −808 | 36 953 | −2,14 | 86,14 | −69 601 | 3 183 131 |
2013-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 500 | 37 761 | −3,82 | 91,78 | −137 670 | 3 465 705 |
2013-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −572 | 39 261 | −1,44 | 89,60 | −51 251 | 3 517 786 |
2013-04-01 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 16 700 | 16 700 | |||||
2013-04-01 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
A - Award | 6 000 | 39 833 | 17,73 | ||||
2013-03-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −796 | 29 445 | −2,63 | ||||
2013-03-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −584 | 21 583 | −2,63 | ||||
2013-03-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −802 | 20 053 | −3,85 | ||||
2013-03-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −657 | 8 531 | −7,15 | ||||
2013-03-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −1 215 | 19 758 | −5,79 | ||||
2013-03-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 054 | 33 833 | −10,70 | 79,72 | −323 185 | 2 697 167 |
2013-03-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 796 | 37 887 | 2,15 | 37,68 | 29 993 | 1 427 582 | |
2013-03-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 584 | 37 091 | 1,60 | 37,68 | 22 005 | 1 397 589 | |
2013-03-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 802 | 36 507 | 2,25 | 35,18 | 28 214 | 1 284 316 | |
2013-03-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 657 | 35 705 | 1,87 | 30,28 | 19 894 | 1 081 147 | |
2013-03-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 215 | 35 048 | 3,59 | 32,07 | 38 965 | 1 123 989 | |
2013-02-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −796 | 30 241 | −2,56 | ||||
2013-02-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −583 | 22 167 | −2,56 | ||||
2013-02-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −802 | 20 855 | −3,70 | ||||
2013-02-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −656 | 9 188 | −6,66 | ||||
2013-02-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −1 214 | 20 973 | −5,47 | ||||
2013-02-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 051 | 33 833 | −10,69 | 77,52 | −314 034 | 2 622 734 |
2013-02-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 796 | 37 884 | 2,15 | 37,68 | 29 993 | 1 427 469 | |
2013-02-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 583 | 37 088 | 1,60 | 37,68 | 21 967 | 1 397 476 | |
2013-02-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 802 | 36 505 | 2,25 | 35,18 | 28 214 | 1 284 246 | |
2013-02-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 656 | 35 703 | 1,87 | 30,28 | 19 864 | 1 081 087 | |
2013-02-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 214 | 35 047 | 3,59 | 32,07 | 38 933 | 1 123 957 | |
2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −2 388 | 31 037 | −7,14 | ||||
2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −1 050 | 22 750 | −4,41 | ||||
2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −802 | 21 657 | −3,57 | ||||
2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −656 | 9 844 | −6,25 | ||||
2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −1 344 | 22 187 | −5,71 | ||||
2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 500 | 33 833 | −4,25 | 81,99 | −122 985 | 2 773 968 |
2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 740 | 35 333 | −11,83 | 81,12 | −384 509 | 2 866 213 |
2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 388 | 40 073 | 6,34 | 37,68 | 89 980 | 1 509 951 | |
2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 050 | 37 685 | 2,87 | 37,68 | 39 564 | 1 419 971 | |
2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 802 | 36 635 | 2,24 | 35,18 | 28 214 | 1 288 819 | |
2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 656 | 35 833 | 1,86 | 30,28 | 19 864 | 1 085 023 | |
2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 344 | 35 177 | 3,97 | 32,07 | 43 102 | 1 128 126 | |
2012-12-12 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −4 775 | 33 425 | −12,50 | ||||
2012-12-12 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −2 100 | 23 800 | −8,11 | ||||
2012-12-12 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −3 208 | 22 459 | −12,50 | ||||
2012-12-12 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −656 | 10 500 | −5,88 | ||||
2012-12-12 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −1 345 | 23 531 | −5,41 | ||||
2012-12-12 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −14 398 | 33 833 | −29,85 | 77,68 | −1 118 437 | 2 628 147 |
2012-12-12 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 775 | 48 231 | 10,99 | 37,68 | 179 922 | 1 817 344 | |
2012-12-12 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 100 | 43 456 | 5,08 | 37,68 | 79 128 | 1 637 422 | |
2012-12-12 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 208 | 41 356 | 8,41 | 35,18 | 112 857 | 1 454 904 | |
2012-12-12 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 656 | 38 148 | 1,75 | 30,28 | 19 864 | 1 155 121 | |
2012-12-12 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 345 | 37 492 | 3,72 | 32,07 | 43 134 | 1 202 368 | |
2012-11-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −1 344 | 24 876 | −5,13 | ||||
2012-11-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −657 | 11 156 | −5,56 | ||||
2012-11-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 001 | 36 147 | −5,25 | 75,14 | −150 355 | 2 716 086 |
2012-11-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 344 | 38 148 | 3,65 | 32,07 | 43 102 | 1 223 406 | |
2012-11-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 657 | 36 804 | 1,82 | 30,28 | 19 894 | 1 114 425 | |
2012-10-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −1 344 | 26 220 | −4,88 | ||||
2012-10-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −656 | 11 813 | −5,26 | ||||
2012-10-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 36 147 | −5,24 | 91,01 | −182 020 | 3 289 738 |
2012-10-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 344 | 38 147 | 3,65 | 32,07 | 43 102 | 1 223 374 | |
2012-10-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 656 | 36 803 | 1,81 | 30,28 | 19 864 | 1 114 395 | |
2012-09-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −1 345 | 27 564 | −4,65 | ||||
2012-09-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −656 | 12 469 | −5,00 | ||||
2012-09-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 001 | 42 397 | −4,51 | 77,88 | −155 838 | 3 301 878 |
2012-09-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 345 | 44 398 | 3,12 | 32,07 | 43 134 | 1 423 844 | |
2012-09-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 656 | 43 053 | 1,55 | 30,28 | 19 864 | 1 303 645 | |
2012-09-06 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 721 | 42 397 | −3,90 | 72,78 | −125 254 | 3 085 654 |
2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options (Right to Buy) |
M - Exercise | −12 833 | 25 667 | −33,33 | ||||
2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options (Right to Buy) |
M - Exercise | −2 100 | 25 900 | −7,50 | ||||
2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options (Right to Buy) |
M - Exercise | −1 344 | 28 909 | −4,44 | ||||
2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options (Right to Buy) |
M - Exercise | −656 | 13 125 | −4,76 | ||||
2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −14 933 | 44 118 | −25,29 | 71,97 | −1 074 728 | 3 175 172 |
2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 59 051 | −3,28 | 71,79 | −143 580 | 4 239 271 |
2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12 833 | 61 051 | 26,61 | 35,18 | 451 465 | 2 147 774 | |
2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 100 | 48 218 | 4,55 | 37,68 | 79 128 | 1 816 854 | |
2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 344 | 46 118 | 3,00 | 32,07 | 43 102 | 1 479 004 | |
2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 656 | 44 774 | 1,49 | 30,28 | 19 864 | 1 355 757 | |
2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | −6 550 | 44 118 | −12,93 | 71,93 | −471 146 | 3 173 439 | |
2012-07-27 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 971 | 50 668 | −5,54 | 73,97 | −219 770 | 3 747 993 |
2012-07-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −7 719 | 13 781 | −35,90 | ||||
2012-07-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −16 747 | 30 526 | −35,43 | ||||
2012-07-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 265 | 53 639 | −7,37 | 68,53 | −292 280 | 3 675 881 |
2012-07-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −20 201 | 57 904 | −25,86 | 67,49 | −1 363 365 | 3 907 941 |
2012-07-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 719 | 78 105 | 10,97 | 30,28 | 233 731 | 2 365 019 | |
2012-07-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 16 747 | 70 386 | 31,22 | 32,07 | 537 076 | 2 257 279 | |
2012-06-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −10 000 | 21 500 | −31,75 | ||||
2012-06-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −30 000 | 47 000 | −38,96 | ||||
2012-06-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 53 639 | −15,71 | 44,44 | −444 351 | 2 383 454 |
2012-06-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 63 639 | −13,58 | 44,48 | −444 750 | 2 830 345 |
2012-06-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 73 639 | −11,96 | 44,61 | −446 146 | 3 285 375 |
2012-06-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 000 | 83 639 | −4,56 | 44,58 | −178 334 | 3 728 911 |
2012-06-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 000 | 87 639 | −3,31 | 44,60 | −133 800 | 3 908 699 |
2012-06-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 000 | 90 639 | −3,20 | 44,57 | −133 710 | 4 039 780 |
2012-06-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 000 | 93 639 | 11,96 | 30,28 | 302 800 | 2 835 389 | |
2012-06-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 30 000 | 83 639 | 55,93 | 32,07 | 962 100 | 2 682 303 | |
2012-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | X | −694 | 53 639 | −1,28 | 36,58 | −25 385 | 1 962 013 |
2012-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | X | −568 | 54 333 | −1,03 | 36,58 | −20 776 | 1 987 376 |
2012-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 28 000 | 28 000 | |||||
2012-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 38 200 | 38 200 | |||||
2012-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
A - Award | 17 150 | 54 901 | 45,43 | ||||
2012-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
A - Award | 7 500 | 37 751 | 24,79 |